Cargando…
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
BACKGROUND: The Coalition for Epidemic Preparedness Innovations was established in 2016, to develop vaccines that can contribute to preparedness for outbreaks of epidemic infectious diseases. Evidence on vaccine development costs for such diseases is scarce. Our goal was to estimate the minimum cost...
Autores principales: | Gouglas, Dimitrios, Thanh Le, Tung, Henderson, Klara, Kaloudis, Aristidis, Danielsen, Trygve, Hammersland, Nicholas Caspersen, Robinson, James M, Heaton, Penny M, Røttingen, John-Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164811/ https://www.ncbi.nlm.nih.gov/pubmed/30342925 http://dx.doi.org/10.1016/S2214-109X(18)30346-2 |
Ejemplares similares
-
R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a New Coalition
por: Gopinathan, Unni, et al.
Publicado: (2020) -
Prioritizing investments in new vaccines against epidemic infectious diseases: A multi‐criteria decision analysis
por: Gouglas, Dimitrios, et al.
Publicado: (2019) -
Minimising the use of costly control measures in an epidemic elimination strategy: A simple mathematical model
por: Plank, Michael J.
Publicado: (2022) -
The need for global R&D coordination for infectious diseases with epidemic potential
por: Kieny, Marie Paule, et al.
Publicado: (2016) -
A cost minimisation analysis of a telepaediatric otolaryngology service
por: Xu, Cathy Q, et al.
Publicado: (2008)